CRISPR Cas9 screens for drug resistance in AML cell lines
收藏官方服务：
资源简介：
CRISPR Cas9 screens for drug resistance in AML cell lines
应用场景：
创建时间：
2015-02-03
相关数据集
RNF25-Mediated NF-κB Activation Drives Anti-Apoptosis and Therapy Resistance in Cancer
RNF25-Mediated NF-κB Activation Drives Anti-Apoptosis and Therapy Resistance in Cancer
integrated proteome resources90
Network-based elucidation of colon cancer drug resistance by phosphoproteomic time-series analysis
Aberrant signaling pathway activity is a hallmark of tumorigenesis and progression, which has guided targeted inhibitor design for over 30 years. Yet, adaptive resistance mechanisms, induced by rapid,
NIAID Data Ecosystem70
Differential gene expression (FDR 0.05) for CRISPR edited clones.
hTLR4 Cells were transfected a CRISPR/Cas9 construct and a gRNA specific for the rs17622517 locus. Wild type, heterozygous or homozygous clones were isolated and then treated with no LPS, LPS for 90 m
Figshare2021-07-27 更新10
Transcriptional profiling of parental mouse erythroleukemia (MEL) and HMBA-resistant (MEL-R) cells
We have previously isolated a murine erythroleukemia cell line refractive to re-enter a cell differentiation program as opposite to the progenitor cell line. We use RNA-seq to identify differentially
NIAID Data Ecosystem70
Cytotoxicity of Ruthenium–Arene Complexes Containing β‑Ketoamine Ligands
New ruthenium(II) arene derivatives (arene = p-cymene, benzene, hexamethylbenzene) containing β-ketoamine ligands L′ (HL′ in general; in detail, HLph,ph = (4Z)-3-methyl-4-((phenylamino)(phenyl)meth
NIAID Data Ecosystem50
